Lazard Asset Management
SHC icon

Lazard Asset Management’s Sotera Health SHC Stock Holding History

Lazard Asset Management’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
57,078
-125,853
-69% -$1.98M ﹤0.01% 1226
2026
Q1 		$2.62M Buy
182,931
+138,636
+313% +$2.3M ﹤0.01% 779
2025
Q4 		$781K Buy
44,295
+3,757
+9% +$62.1K ﹤0.01% 1224
2025
Q3 		$638K Buy
40,538
+5,564
+16% +$78.1K ﹤0.01% 1274
2025
Q2 		$388K Buy
34,974
+24,395
+231% +$286K ﹤0.01% 1565
2025
Q1 		$122K Buy
10,579
+3,955
+60% +$50.9K ﹤0.01% 1758
2024
Q4 		$89K Sell
6,624
-2,380
-26% -$34.5K ﹤0.01% 1836
2024
Q3 		$149K Buy
9,004
+1,962
+28% +$28.7K ﹤0.01% 1676
2024
Q2 		$82K Buy
7,042
+3,190
+83% +$36.4K ﹤0.01% 1810
2024
Q1 		$46K Sell
3,852
-2,784
-42% -$41.4K ﹤0.01% 1734
2023
Q4 		$110K Sell
6,636
-4,344
-40% -$61.5K ﹤0.01% 1621
2023
Q3 		$163K Buy
10,980
+2,083
+23% +$35.1K ﹤0.01% 1457
2023
Q2 		$167K Sell
8,897
-1,929
-18% -$30.7K ﹤0.01% 1403
2023
Q1 		$193K Buy
10,826
+918
+9% +$15.3K ﹤0.01% 1320
2022
Q4 		$82K Buy
9,908
+1,217
+14% +$9.08K ﹤0.01% 1603
2022
Q3 		$59K Sell
8,691
-4,660,379
-100% -$77.5M ﹤0.01% 1728
2022
Q2 		$91.5M Sell
4,669,070
-687,312
-13% -$14.4M 0.12% 152
2022
Q1 		$116M Sell
5,356,382
-343,159
-6% -$7.28M 0.13% 145
2021
Q4 		$134M Sell
5,699,541
-347,774
-6% -$8.32M 0.14% 129
2021
Q3 		$158M Buy
6,047,315
+1,336
+0% +$32.3K 0.18% 101
2021
Q2 		$146M Buy
6,045,979
+273,239
+5% +$6.72M 0.16% 108
2021
Q1 		$144M Buy
5,772,740
+2,120,909
+58% +$56.1M 0.17% 108
2020
Q4 		$100M Buy
+3,651,831
New +$98M 0.13% 143

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Lazard Asset Management's SHC Position: Q2 2026 in Review

Lazard Asset Management reduced its Sotera Health (SHC) stake by 69% in Q2 2026, selling an estimated $1.98M and leaving 57,078 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Lazard Asset Management first reported a position in SHC in Q4 2020 and has held it in 23 quarters since. The position peaked at $158M in Q3 2021. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Lazard Asset Management held 57,078 shares of Sotera Health worth $1.01M as of Q2 2026.
  • Lazard Asset Management sold 125,853 Sotera Health shares in Q2 2026, an estimated $1.98M.
  • Sotera Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1226 holding.
  • Lazard Asset Management first reported a position in Sotera Health in Q4 2020 and has held it in 23 quarters since.
  • Lazard Asset Management's Sotera Health position peaked at $158M in Q3 2021.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.